MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

In-process research anddevelopment$2,260K Operating leaseright-of-use assets net$457K Restricted cash securitydeposit$200K Leasehold improvementsand equipment net$138K Finance leaseright-of-use assets net$4K Cash and cashequivalents$2,398K Prepaid expenses andother current assets$367K Restricted cash securitydeposit$50K Total non-currentassets$3,059K Total current assets$2,815K Total assets$5,874K Total liabilities andstockholders equity$5,874K Total stockholdersequity$3,022K Total liabilities$2,852K Accumulated deficit-$212,708K Additional paid-in capital$215,729K Total currentliabilities$2,126K Total non-currentliabilities$726K Common stock par value0.0001 per share,...$1K Operating leaseliabilities current$718K Accounts payable$712K Accrued expenses$694K Financing leaseliabilities current$2K Operating leaseliabilities net of current...$464K Deferred tax liability$257K Financing leaseliabilities net of current...$5K
Balance Sheet

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. (MTNB)

source: myfinsight.com